These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Changes in oxidative activities of chondrocytes during the early development of natural murine osteoarthritis. Dunham J; Chambers MG; Jasani MK; Bitensky L; Chayen J Br J Exp Pathol; 1988 Dec; 69(6):845-53. PubMed ID: 3219287 [TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinases and aggrecanases cleave aggrecan in different zones of normal cartilage but colocalize in the development of osteoarthritic lesions in STR/ort mice. Chambers MG; Cox L; Chong L; Suri N; Cover P; Bayliss MT; Mason RM Arthritis Rheum; 2001 Jun; 44(6):1455-65. PubMed ID: 11407708 [TBL] [Abstract][Full Text] [Related]
5. Effect of inhibition of matrix metalloproteinases on cartilage loss in vitro and in a guinea pig model of osteoarthritis. Sabatini M; Lesur C; Thomas M; Chomel A; Anract P; de Nanteuil G; Pastoureau P Arthritis Rheum; 2005 Jan; 52(1):171-80. PubMed ID: 15641085 [TBL] [Abstract][Full Text] [Related]
6. Chondrocyte matrix metalloproteinase-8: up-regulation of neutrophil collagenase by interleukin-1 beta in human cartilage from knee and ankle joints. Chubinskaya S; Huch K; Mikecz K; Cs-Szabo G; Hasty KA; Kuettner KE; Cole AA Lab Invest; 1996 Jan; 74(1):232-40. PubMed ID: 8569187 [TBL] [Abstract][Full Text] [Related]
7. Esculetin (dihydroxycoumarin) inhibits the production of matrix metalloproteinases in cartilage explants, and oral administration of its prodrug, CPA-926, suppresses cartilage destruction in rabbit experimental osteoarthritis. Yamada H; Watanabe K; Saito T; Hayashi H; Niitani Y; Kikuchi T; Ito A; Fujikawa K; Lohmander LS J Rheumatol; 1999 Mar; 26(3):654-62. PubMed ID: 10090178 [TBL] [Abstract][Full Text] [Related]
8. Potentiation of para-hydroxyamphetamine-induced head-twitch response by inhibition of monoamine oxidase type A in the brain. Tadano T; Satoh S; Satoh N; Kisara K; Arai Y; Kim SK; Kinemuchi H J Pharmacol Exp Ther; 1989 Jul; 250(1):254-60. PubMed ID: 2501477 [TBL] [Abstract][Full Text] [Related]
9. Changes in the orientation of proteoglycans during the early development of natural murine osteoarthritis. Dunham J; Chambers MG; Jasani MK; Bitensky L; Chayen J J Orthop Res; 1990 Jan; 8(1):101-4. PubMed ID: 2293624 [TBL] [Abstract][Full Text] [Related]
10. Ocular hypotensive effects of monoamine oxidase-A inhibitors in rabbit. Maeda I; Ueda T; Koide R; Inatomi M; Fukado Y; Uchida E; Oguchi K; Yasuhara H Jpn J Ophthalmol; 1988; 32(2):211-8. PubMed ID: 3184554 [TBL] [Abstract][Full Text] [Related]
11. [Activity of mouse cerebral monoamine oxidase as a function of the means of administration of a MAO inhibitor]. Levy J; Michel-Ber E Therapie; 1966; 21(3):633-44. PubMed ID: 5942129 [No Abstract] [Full Text] [Related]
12. [Effect of benzamide derivatives on rat brain monoamine oxidase activity in vitro]. Gol'dina OA; Zagorevskiĭ VA; Lopatina KI; Sokolova TV; Gankina EM Biull Eksp Biol Med; 1986 Aug; 102(8):170-2. PubMed ID: 3742029 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver. Ozaita A; Olmos G; Boronat MA; Lizcano JM; Unzeta M; García-Sevilla JA Br J Pharmacol; 1997 Jul; 121(5):901-12. PubMed ID: 9222546 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic applications of selective and non-selective inhibitors of monoamine oxidase A and B that do not cause significant tyramine potentiation. Youdim MB; Weinstock M Neurotoxicology; 2004 Jan; 25(1-2):243-50. PubMed ID: 14697899 [TBL] [Abstract][Full Text] [Related]
15. Isolation and characterization of a monoamine oxidase B selective inhibitor from tobacco smoke. Khalil AA; Davies B; Castagnoli N Bioorg Med Chem; 2006 May; 14(10):3392-8. PubMed ID: 16458520 [TBL] [Abstract][Full Text] [Related]
16. High-throughput screening for monoamine oxidase-A and monoamine oxidase-B inhibitors using one-step fluorescence assay. Guang HM; Du GH Acta Pharmacol Sin; 2006 Jun; 27(6):760-6. PubMed ID: 16723097 [TBL] [Abstract][Full Text] [Related]
17. Effect of quercetin and glucuronide metabolites on the monoamine oxidase-A reaction in mouse brain mitochondria. Yoshino S; Hara A; Sakakibara H; Kawabata K; Tokumura A; Ishisaka A; Kawai Y; Terao J Nutrition; 2011; 27(7-8):847-52. PubMed ID: 21371861 [TBL] [Abstract][Full Text] [Related]
18. Degenerative knee joint lesions in mice after a single intra-articular collagenase injection. A new model of osteoarthritis. van der Kraan PM; Vitters EL; van Beuningen HM; van de Putte LB; van den Berg WB J Exp Pathol (Oxford); 1990 Feb; 71(1):19-31. PubMed ID: 2155638 [TBL] [Abstract][Full Text] [Related]
19. The nature of inhibition of thyroid monoamine oxidase by thyroxine in rat thyroid. Knopp J Endokrinologie; 1982 Nov; 80(3):367-70. PubMed ID: 7166166 [TBL] [Abstract][Full Text] [Related]
20. E2011 a novel, selective and reversible inhibitor of monoamine oxidase type A. Kagaya T; Kajiwara A; Nagato S; Akasaka K; Kubota A J Pharmacol Exp Ther; 1996 Jul; 278(1):243-51. PubMed ID: 8764357 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]